#20 Do No Harm | Dr. Michael Verbora

April 6, 2021
Podcast / Icon / Play Created with Sketch.
Timeline Created with Sketch.
Combined Shape Created with Sketch.
Listen on
Apple Podcasts
Fill 1 Created with Sketch.
Listen on
Spotify
simplecast Created with Sketch.
Listen on
Simplecast
google-podcasts Created with Sketch.
Listen on
Google Podcasts
heart Created with Sketch.
Listen on
iHeart

Share this:

2.19 - How Michael started working in psychedelics.


3.44 - Michael’s initial thoughts and trials with cannabis and psychedelic research. 


6.00 - Why Michael went to medical school in the first place. 


7.40 - Michael expands on the culture of medicine and its incongruence with his values. 


9.00 - Ronan discusses the similarities between his and Michael’s story. 


10.03 - The risk of falling outside the norm in medicine. 


12.48 - The challenges within the North American medical system. 


13.32 -  The “patient-centred” medical system. 


15.16 - Why psychedelics are more effective for treating mental health disorders. 


18.24 - What happens when you take psychedelic molecules. 


20.37 - Michael’s take on the materialist vs. dualist debate. 


25.02 - Michael’s experiences on psychedelics. 


30.21 - Michael’s inward experience with ketamine. 


33.35 - What can we do to advance the conversation about psychedelics in a medical context. 


35.50 - What impact Michael has seen psychedelics have on today’s mental health challenge. 


40.30 - How psychedelic medicine is going to change medicine by normalizing an integrative approach.  


Transcripts

Collapse
Expand

About Ronan

An entrepreneur and a visionary, Ronan is one the founders of Field Trip – with a mission to bring the world to life through psychedelics and psychedelic-enhanced psychotherapy. Concurrent with his work at Field Trip, he is a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences Inc., a leading biotech company in the hemp and cannabis industries. Prior to his current roles, Ronan co-founded Canadian Cannabis Clinics and CanvasRx Inc., the latter of which was acquired by Aurora Cannabis Inc. (NYSE: ACB) in 2016, after which he served as Senior Vice President, Business and Corporate Affairs for Aurora. A lawyer by training, Ronan started his career as a corporate lawyer at Blake, Cassels Graydon LLP and Legal Counsel at CTVglobemedia Inc. (now Bell Media Inc.) He holds a Juris Doctor and a Bachelor of Commerce degree, both from the University of Toronto.